beta-lactams has been researched along with Tuberculosis, Drug-Resistant in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (12.50) | 29.6817 |
2010's | 10 (62.50) | 24.3611 |
2020's | 4 (25.00) | 2.80 |
Authors | Studies |
---|---|
Fontaine, E; Roubert, C; Upton, AM | 1 |
Bozdogan, B; Coban, AY; Gun, MA | 1 |
Drobniewski, F; Gonzalo, X; McHugh, TD; Ortiz Canseco, J; Satta, G | 1 |
Bedő, J; Conway, TC; Faux, NG; Goudey, BW; Trigos, AS; Wyres, KL | 1 |
Alffenaar, JC; Gumbo, T; Srivastava, S; van Rijn, SP; van Soolingen, D; Wessels, MA | 1 |
Chang, KC; Leung, CC; Tam, CM; Yew, WW | 1 |
Bhattacharyya, RP; Hung, DT; Wivagg, CN | 1 |
Alffenaar, JW; Centis, R; D'Ambrosio, L; De Lorenzo, S; Migliori, GB; Sotgiu, G; Tiberi, S; Viggiani, P | 1 |
Akkerman, OW; Alffenaar, JW; de Lange, WC; Kosterink, JG; van Altena, R; van der Laan, T; van der Werf, TS; van Rijn, SP; van Soolingen, D | 1 |
Centis, R; D'Ambrosio, L; Dore, S; Esposito, S; Migliori, GB; Sotgiu, G; Spanevello, A; Tiberi, S | 1 |
Ballell, L; Barnard, M; Barros-Aguirre, D; Diacon, AH; García-Basteiro, AL; Lange, C; Sevene, E; van der Merwe, L; von Groote-Bidlingmaier, F | 1 |
Deshpande, D; Gumbo, T; Nuermberger, E; Pasipanodya, JG; Srivastava, S; Swaminathan, S | 1 |
Drobniewski, F; Gonzalo, X | 1 |
Bonomo, RA; Kurz, SG | 1 |
Dinçer, I; Ergin, A; Kocagöz, T | 1 |
Danilchanka, O; Mailaender, C; Niederweis, M | 1 |
5 review(s) available for beta-lactams and Tuberculosis, Drug-Resistant
Article | Year |
---|---|
Tuberculosis and beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2020 |
WHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis.
Topics: Acetamides; Adult; Antitubercular Agents; beta-Lactams; Clofazimine; Cohort Studies; Databases, Bibliographic; Female; Fluoroquinolones; Humans; Isoniazid; Linezolid; Macrolides; Male; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2013 |
Mechanisms of β-lactam killing and resistance in the context of Mycobacterium tuberculosis.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Drug Therapy, Combination; Humans; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review.
Topics: Antitubercular Agents; beta-Lactams; Carbapenems; Clinical Studies as Topic; Ertapenem; Extensively Drug-Resistant Tuberculosis; Humans; Imipenem; Meropenem; Thienamycins; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2016 |
Reappraising the use of β-lactams to treat tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cell Wall; Humans; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2012 |
11 other study(ies) available for beta-lactams and Tuberculosis, Drug-Resistant
Article | Year |
---|---|
"Upcycling" known molecules and targets for drug-resistant TB.
Topics: Antitubercular Agents; beta-Lactams; Ethionamide; Humans; Spectinomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution.
Topics: Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2020 |
Collateral Sensitivity to β-Lactam Drugs in Drug-Resistant Tuberculosis Is Driven by the Transcriptional Wiring of BlaI Operon Genes.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Computer Simulation; Gene Expression; Gene Expression Profiling; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Operon; Transcription, Genetic; Tuberculosis, Multidrug-Resistant | 2021 |
Sterilizing Effect of Ertapenem-Clavulanate in a Hollow-Fiber Model of Tuberculosis and Implications on Clinical Dosing.
Topics: Antitubercular Agents; beta-Lactams; Clavulanic Acid; Computer Simulation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ertapenem; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience.
Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; beta-Lactams; Drug Therapy, Combination; Ertapenem; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Middle Aged; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Pharmacokinetics of ertapenem in patients with multidrug-resistant tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Area Under Curve; beta-Lactams; Ertapenem; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Netherlands; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
β-Lactams against Tuberculosis--New Trick for an Old Dog?
Topics: Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; beta-Lactamase Inhibitors; beta-Lactams; Colony Count, Microbial; Drug Discovery; Humans; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2016 |
A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way.
Topics: Antitubercular Agents; Bacterial Load; beta-Lactams; Child; Computer Simulation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Models, Theoretical; Moxifloxacin; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2016 |
Is there a place for β-lactams in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin/clavulanate.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Clavulanic Acid; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Thienamycins; Tuberculosis, Multidrug-Resistant | 2013 |
The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Culture Media; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.
Topics: Ampicillin Resistance; ATP-Binding Cassette Transporters; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethidium; Genes, Bacterial; Humans; Membrane Transport Proteins; Models, Biological; Molecular Sequence Data; Mutagenesis, Insertional; Mycobacterium bovis; Mycobacterium smegmatis; Mycobacterium tuberculosis; Transcription, Genetic; Tuberculosis, Multidrug-Resistant | 2008 |